Changes in the Level of Antiphospholipid Antibodies (Anticardiolipin and Anti-β2-Glycoprotein-I) and Thromboembolic Indices in COVID-19 Patients during 3 Weeks

INTRODUCTION: COVID-19 is a respiratory disease caused by infection with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Thrombotic complications appear to be of particular importance in patients with COVID-19. This study aimed to investigate Changes in the level of Antiphospholipid an...

Descripción completa

Detalles Bibliográficos
Autores principales: Haghighipour, Somayeh, Salesi, Mansour, Keikhaei, Fereshteh, Tarrahi, Mohammad J., Khani, Zahra, Salehi, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284197/
https://www.ncbi.nlm.nih.gov/pubmed/37351036
http://dx.doi.org/10.4103/ijpvm.ijpvm_377_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284197/
https://www.ncbi.nlm.nih.gov/pubmed/37351036
http://dx.doi.org/10.4103/ijpvm.ijpvm_377_21

Ejemplares similares